PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s
Juan Carlos Corona(University College London), Michael R. Duchen(MRC Laboratory for Molecular Cell Biology)
Cited by 163
Related Papers
Constitutive activation of the PI3K-Akt-mTORC1 pathway sustains the m.3243 A > G mtDNA mutation
|Nature Communications|2021|54
Impaired cellular bioenergetics caused by GBA1 depletion sensitizes neurons to calcium overload
|Cell Death and Differentiation|2019|41
Investigating the Mitochondrial Permeability Transition Pore in Disease Phenotypes and Drug Screening
|Current Protocols in Pharmacology|2019|27